How is Selank administered?
This describes how Selank is typically administered in clinical and research references, not a self-administration guide. The usual route is Intranasal spray (sub-q also used), on a 1-3x daily schedule, generally over 2-4 weeks on, equal time off. Specific dosing is individual and beyond general information, and human evidence for Selank is limited.
Administration at a glance (reference data)
- Route: Intranasal spray (sub-q also used)
- Schedule: 1-3x daily
- Cycle length: 2-4 weeks on, equal time off
- Half-life: ~30 minutes (intranasal)
References
- Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity — Vyunova TV, Andreeva L, Shevchenko K, Myasoedov N. Protein and Peptide Letters, 2018
- Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats — Kasian A, Kolomin T, Andreeva L, Bondarenko E, Myasoedov N, Slominsky P, Shadrina M. Behavioural Neurology, 2017
- Rapid and slow response during treatment of generalized anxiety disorder with peptide anxiolytic selank — European Psychiatry (EPA congress abstract P-1114), via ScienceDirect, 2012
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Selank
Last updated 2026-06-15.